Antiretroviral therapies (ART) stop HIV replication in its tracks, allowing people with HIV to live relatively normal lives. However, despite these treatments, some HIV still lingers inside cells in a dormant state known ...
Feb 13, 2024
0
1
About 6% of people in the UK are wrongly labeled on their medical records as being allergic to penicillin, the Royal Pharmaceutical Society has warned.
Oct 5, 2023
0
30
Scientists at The Wistar Institute have discovered a potential target for gastric cancers associated with Epstein-Barr Virus, and their study results are published in the journal mBio.
Aug 22, 2023
0
22
A University of Ottawa-led research team has published new research that advances a quest to understand an ultra-rare disease that's found almost exclusively in boys. The study was published in PLOS Pathogens.
Aug 3, 2023
0
20
Since Fall 2021, an increasing number of unexplained cases of severe acute hepatitis have been reported in children. Epidemiologic investigation is ongoing, and, to date, a cause of these outbreaks has not been identified. ...
Jul 28, 2023
0
1
While most people survive and recover from COVID, for some people symptoms can persist for months or years. When symptoms last longer than 12 weeks, the condition is known as long COVID.
Jun 9, 2023
0
8
A team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) has discovered that a transcription factor, TOX2, was aberrantly increased in patients with ...
May 29, 2023
0
28
An estimated 2.8 million people around the world have multiple sclerosis (MS), an autoimmune disease in which the immune system damages the brain and spinal cord.
May 22, 2023
0
6
Medical science has not yet been able to explain why the Epstein-Barr virus triggers infectious mononucleosis (IM) in some people with initial infections and not in others. But now, a research team led by Elisabeth Puchhammer-Stöckl, ...
Jan 19, 2023
0
9
For patients undergoing liver transplant (LT), Epstein-Barr virus (EBV) viral load (VL) monitoring may reduce the incidence of posttransplant lymphoproliferative disease (PTLD), according to a study published online Jan. ...
Jan 18, 2023
0
2
